Literature DB >> 1000525

The molecular-weight range of mucosal-heparin preparations.

E A Johnson, B Mulloy.   

Abstract

A recently reported method describes the determination of the molecular-weight range of heparins by using an electrofocusing procedure to isolate individual molecular species. Commercially available heparins were fractionated on a column of polyacrylamide-agarose gel to give fractions whose molecular weights were estimated by viscometry. Fractions with mutually exclusive molecllar-weight ranges gave an appreciable number of common bands when subjected to the electrofocusing procedure; therefore, each of these bands cannot be formed from a single molecular species of heparin. Other mucopolysaccharides also gave band sequences indistinguishable from those of heparin; they differed in position and intensity with different ampholyte batches, and probably arose from individual molecular species of the ampholyte rather than the mucopolysaccharide. The molecular-weight range of the heparin was observed to be broader than that usually reported.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000525     DOI: 10.1016/s0008-6215(00)84041-0

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  13 in total

Review 1.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

2.  Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Authors:  Kyohei Higashi; Saori Hosoyama; Asami Ohno; Sayaka Masuko; Bo Yang; Eric Sterner; Zhenyu Wang; Robert J Linhardt; Toshihiko Toida
Journal:  Carbohydr Polym       Date:  2012-02-01       Impact factor: 9.381

3.  The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.

Authors:  E Holmer; K Kurachi; G Söderström
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

4.  Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.

Authors:  M K Patel; J S Refson; M Schachter; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  The assay and partial characterization of macromolecular heparin depolymerase activity in rat small intestine.

Authors:  E Young; A A Horner
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

6.  Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.

Authors:  Kyohei Higashi; Mellisa Ly; Zhenyu Wang; Sayaka Masuko; Ujjwal Bhaskar; Eric Sterner; Fuming Zhang; Toshihiko Toida; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2011-08-01       Impact factor: 9.381

7.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

Review 8.  The design and synthesis of new synthetic low-molecular-weight heparins.

Authors:  K Chandarajoti; J Liu; R Pawlinski
Journal:  J Thromb Haemost       Date:  2016-04-15       Impact factor: 5.824

Review 9.  Low molecular weight heparins. An objective overview.

Authors:  D Hoppensteadt; J M Walenga; J Fareed
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

10.  The relative molecular mass dependence of the anti-factor Xa properties of heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.